Vetoquinol SA Logo

Vetoquinol SA

Develops and markets veterinary medicines for companion animals and livestock.

VETO | PA

Overview

Corporate Details

ISIN(s):
FR0004186856
LEI:
969500YP0AETQIK48R39
Country:
France
Address:
Village, 70200 MAGNY-VERNOIS

Description

Vetoquinol SA is a global animal health company that researches, develops, produces, and markets veterinary medicines and non-medicinal products. The company provides solutions for both companion animals (cats and dogs) and livestock (cattle and pigs). Its product portfolio addresses a wide range of therapeutic areas, including mobility, dermatology, anti-parasitics, antibiotics, internal medicine, and behavior management. Founded in 1933, the independent, family-owned business focuses on innovation and maintaining a close relationship with veterinary professionals to support animal well-being.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-04 11:15
FORMULAIRE DE DECLARATION D'ACTIONS ET DE DROITS DE VOTE
French PDF 372.7 KB
2025-11-07 09:10
FORMULAIRE DE DECLARATION D'ACTIONS ET DE DROITS DE VOTE
French PDF 369.4 KB
2025-10-28 17:45
Quarterly financial reporting / Third quarter financial report
English PDF 273.2 KB
2025-10-28 17:45
Information financière trimestrielle / Information financière du troisième trim…
French PDF 260.0 KB
2025-10-06 08:45
FORMULAIRE DE DECLATATION D'ACTIONS ET DE DROITS DE VOTE
French PDF 393.9 KB
2025-09-11 17:45
Inside Information / News release on accounts, results
English PDF 216.2 KB
2025-09-11 17:45
Rapports financiers et d'audit semestriels/examens réduits / Rapport financier …
French PDF 226.4 KB
2025-09-11 17:45
Informations privilégiées / Communiqué sur comptes, résultats
French PDF 219.1 KB
2025-09-04 15:45
FORMULAIRE DE DECLARATION D'ACTIONS ET DE DROITS DE VOTE
French PDF 376.1 KB
2025-08-05 15:00
FORMULAIRE DE DECLARATION D'ACTIONS ET DE DROITS DE VOTE
French PDF 737.7 KB
2025-07-03 09:00
FORMULAIRE DE DECLARATION D'ACTIONS ET DE DROITS DE VOTE
French PDF 378.4 KB
2025-06-06 14:45
FORMULAIRE DE DECLARATION D'ACTONS ET DE DROITS DE VOTE
French PDF 374.6 KB
2025-05-05 15:00
FORMULAIRE DE DECLARATION D'ACTIONS ET DE DROITS DE VOTE
French PDF 372.0 KB
2025-04-25 10:26
Terms of availability of the information and the report on corporate governance
English PDF 535.3 KB
2025-04-25 10:26
Modalités de mise à disposition de l’information et du rapport sur gouvernement…
French PDF 536.8 KB

Automate Your Workflow. Get a real-time feed of all Vetoquinol SA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Vetoquinol SA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Vetoquinol SA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-07-25 N/A Other Sell 4,000 399,600.00 EUR
2024-07-25 N/A Other Buy 4,000 399,600.00 EUR
2024-03-21 N/A Other Sell 3,500 346,500.00 EUR
2024-03-21 N/A Other Buy 3,500 346,500.00 EUR
2024-01-03 N/A Other Buy 1,800 182,880.00 EUR
2023-11-16 N/A Other Buy 1,000 87,500.00 EUR
2023-11-13 N/A Other Sell 1,000 87,500.00 EUR
2023-09-08 N/A Other Buy 400 33,960.00 EUR

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.